Rima Alameddine Named President of BD Peripheral Intervention
May 2024- BD announced that Rima Alameddine has been named worldwide president of the BD Peripheral Intervention business unit.In this role, Alameddine will be responsible... Read more.
AbbVie Completes Acquisition of Landos Biopharma
North Chicago- May 2024- AbbVie announced that it has completed its acquisition of Landos Biopharma, With the completion of the acquisition, Landos is now part of... Read more.
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030
May 2024- AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant... Read more.
Siemens Healthineers Launches New Cardiology Apps for Acuson Sequoia Ultrasound
May 2024- Siemens Healthineers announces new cardiology applications with artificial intelligence for the Acuson Sequoia ultrasound system, as well as a new 4D transesophageal... Read more.
Philips expands global access to its 3D intracardiac echocardiography to Hong Kong
24 May 2024- Royal Philips announced that the first hospitals in Hong Kong have started using Philips real-time 3D Intracardiac Echocardiography (ICE) catheter –... Read more.
Did COVID-19 Erase a Decade of Progress in Global Life Expectancy?
Geneva- 24 May 2024- The latest edition of the World Health Statistics released by the World Health Organization (WHO) reveals that the COVID-19 pandemic reversed... Read more.
DHA and University of Birmingham Dubai: A New MoU to Boost Healthcare?
Dubai, UAE- May 22, 2024: The Dubai Health Authority (DHA) and University of Birmingham Dubai recently signed a MoU to enhance healthcare sector development efforts.... Read more.
Lush Prize announces 2024 winners
May 2024- On May 21st Dr Lorna Ewart, from the Boston USA based organ-on-a-chip company Emulate, received the prestigious Lush Science Prize on stage in London.... Read more.
Atalanta Therapeutics Expands Executive Team with New Appointments
Boston- May 22, 2024- Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, announced the... Read more.
Six-month dosing could simplify treatment to support millions of patients with severe asthma
London, UK- 23 May 2024- GSK announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and safety of... Read more.
